GrantFlow
Sign inGet started
All grants
Grants.govForecastedALN 93.KRPRFA-DK-28-113

Leveraging NAMs to understand disease triggers, discover early biomarkers and develop new classes of therapeutic strategies for Type 1 Diabetes (U01 Clinical Trial Not Allowed)

National Institutes of Health

Amount not specifiedNo deadline
View official posting
Geography
US
Award range
Amount not specified
Cost share
Not specified
Open date
Nov 5, 2026
Close date
—
Opportunity type
Discretionary
Source
Grants.gov

Want grants like this matched to your org automatically?

This is one of thousands. See every grant you qualify for, with the reasoning shown — from $10/mo, cancel anytime.

Check my eligibility

Related grants

Grants.govUS

Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)

National Institutes of Health

Up to $50KCloses in 2 days· Nov 16, 2026
Grants.govUS

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

National Institutes of Health

Amount not specifiedCloses in 3 days· Nov 17, 2026
Grants.govUS

Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)

National Institutes of Health

Amount not specifiedCloses in 3 days· Nov 17, 2026
Grants.govUS

Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)

National Institutes of Health

Up to $350KCloses in 3 days· Nov 17, 2026
Grants.govUS

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

National Institutes of Health

Up to $200KCloses in 3 days· Nov 17, 2026
Grants.govUS

Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)

National Institutes of Health

Amount not specifiedCloses in 4 days· Nov 18, 2026